Notch2 Signaling Is Required for Potent Antitumor Immunity in Vivo

Journal of Immunology - United States
doi 10.4049/jimmunol.0903661
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Alocasia Cucullata Exhibits Strong Antitumor Effect in Vivo by Activating Antitumor Immunity

PLoS ONE
Multidisciplinary
2013English

Notch2, but Not Notch1, Is Required for Proximal Fate Acquisition in the Mammalian Nephron

Development (Cambridge)
Developmental BiologyMolecular Biology
2007English

PD-1 Antitumor Immunity Against Murine H22 Hepatocarcinoma in Vivo

International Journal of Sciences
2018English

YL4073 Is a Potent Autophagy-Stimulating Antitumor Agent in an in Vivo Model of Lewis Lung Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Notch2 Is Required for Maintaining Sustentacular Cell Function in the Adult Mouse Main Olfactory Epithelium

Developmental Biology
Developmental BiologyCell BiologyMolecular Biology
2008English

Rickettsia Conorii Is a Potent Complement Activator in Vivo and Combined Inhibition of Complement and CD14 Is Required for Attenuation of the Cytokine Response Ex Vivo

Immunobiology
AllergyImmunologyHematology
2016English

Palmitoylation Is Required for TNF-R1 Signaling

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2019English

CXCR2 Antibodies for Antitumor Immunity

Science-Business eXchange
2014English

Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice

Clinical Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy